Literature DB >> 111285

Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.

D Ruffing, B Kovacic, S Demetriou, E F Domino.   

Abstract

The narcotic antagonist naloxone was tested to determine its possible interaction with N,N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) in adult male Holtzman rats trained to press a bar on a fixed-ratio four schedule (FR4), i.e., every fourth press earned a reward of 0.01 ml sugar sweetened milk. LSD (0.1 mg/kg) or increasing doses of DMT (1.0, 3.2, and 10.0 mg/kg) were administered i.p. to disrupt food-rewarded fixed ratio bar pressing in a dose related fashion. Pretreatment (5--10 min) with behaviorally ineffective doses of naloxone (1.0--5.6 mg/kg) dramatically enhanced the effects of DMT and LSD. The content of DMT in the brain and liver of rats injected with DMT alone (10 mg/kg) and with a 5 min pretreatment of naloxone (3.2 mg/kg) was determined by radiochemical analysis at 30 and 90 min after 14C-DMT injection. There was no significant difference for either brain or liver 14C-DMT levels when control DMT rats were compared with the naloxone pretreated rats. These results seem to rule out interference by naloxone with the metabolism of DMT as a mechanism of the observed behavioral potentiation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111285     DOI: 10.1007/bf00431949

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Analgesia induced in vivo by central administration of enkephalin in rat.

Authors:  J D Belluzzi; N Grant; V Garsky; D Sarantakis; C D Wise; L Stein
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

2.  Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver.

Authors:  L J Wang Lu; S K Demetriou; E F Domino
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-03

3.  A pharmacological and conceptual reevaluation of hallucinations.

Authors:  R Fischer
Journal:  Confin Psychiatr       Date:  1974

Review 4.  Structure-activity-relationships of certain hallucinogenic substances based on brain levels.

Authors:  W H Vogel; B D Evans
Journal:  Life Sci       Date:  1977-05-15       Impact factor: 5.037

5.  Possible withdrawal from endogeneous opiates in schizophrenics.

Authors:  M Gitlin; M Rosenblatt
Journal:  Am J Psychiatry       Date:  1978-03       Impact factor: 18.112

6.  Intravenous naloxone administration in schizophrenia and affective illness.

Authors:  G C Davis; W E Bunney; E G DeFraites; J E Kleinman; D P van Kammen; R M Post; R J Wyatt
Journal:  Science       Date:  1977-07-01       Impact factor: 47.728

7.  Dimethyltryptamine levels in blood of schizophrenic patients and control subjects.

Authors:  B Angrist; S Gershon; G Sathananthan; R W Walker; B Lopez-Ramos; L R Mandel; W J Vandenheuvel
Journal:  Psychopharmacology (Berl)       Date:  1976-05-05       Impact factor: 4.530

8.  Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations.

Authors:  L Corbett; S T Christian; R D Morin; F Benington; J R Smythies
Journal:  Br J Psychiatry       Date:  1978-02       Impact factor: 9.319

9.  Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat.

Authors:  B Kovacic; L J Wang Lu; D Ruffing; E F Domino
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

10.  Interaction between narcotic antagonist (naloxone) and lysergic acid diethylamide (LSD) in the rat.

Authors:  A P Fertziger; R Fischer
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

View more
  4 in total

1.  Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.

Authors:  T Taşkin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  First dose behavioral tolerance to phencyclidine on food-rewarded bar pressing behavior in the rat.

Authors:  D M Ruffing; E F Domino
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.

Authors:  D M Ruffing; E F Domino
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 4.  Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.

Authors:  Steven A Barker
Journal:  Psychopharmacology (Berl)       Date:  2022-01-22       Impact factor: 4.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.